Top compounds associated with response to TMIE


Feature Type Standardized
Nominal ANOVA
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.085 0.01
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.078 0.01
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.02
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.086 0.02
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.067 0.02
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.02
mRNA Cytarabine GDSC1000 pan-cancer AAC 0.084 0.02
mRNA Z-LLNle-CHO GDSC1000 pan-cancer AAC -0.11 0.02
mRNA isoevodiamine CTRPv2 pan-cancer AAC 0.075 0.02
mRNA lapatinib CCLE pan-cancer AAC 0.1 0.02
Download CSV